
During the Health System Executive Summit, Candy Tsourounis, PharmD, and Elise Wozniak, PharmD got candid about the barriers and financial risk surrounding this innovative therapy.
Sleep restriction may contribute to poor health, including an increased risk for insulin resistance, type 2 diabetes, and obesity. In addition, fewer hours of sleep can adversely affect molecular metabolic pathways in peripheral human adipocytes, according to a clinical study published in the October issue of Annals of Internal Medicine.
